Brigit Biofarmaka Teknologi logo

Brigit Biofarmaka Teknologi (OBAT)

Market Closed
11 Aug, 08:49
IDX IDX
Rp
242. 00
-2
-0.8197%
Rp
172.8B Market Cap
- P/E Ratio
22.37% Div Yield
447,800 Volume
- Eps
Rp 244
Previous Close
Add Transaction
Day Range
240 250
Year Range
190 555
Want to track OBAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OBAT closed today lower at Rp242, a decrease of -0.8197% from yesterday's close, completing a monthly increase of 4.3103% or Rp10. Over the past 12 months, OBAT stock lost -37.6289%.
OBAT is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

OBAT Chart

Brigit Biofarmaka Teknologi (OBAT) FAQ

What is the stock price today?

The current price is Rp242.00.

On which exchange is it traded?

Brigit Biofarmaka Teknologi is listed on IDX.

What is its stock symbol?

The ticker symbol is OBAT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 22.37%.

What is its market cap?

As of today, the market cap is 172.8B.

Has Brigit Biofarmaka Teknologi ever had a stock split?

No, there has never been a stock split.

Brigit Biofarmaka Teknologi Profile

- Industry
- Sector
- CEO
IDX Exchange
- ISIN
Indonesia Country
22 Employees
22 May 2026 Last Dividend
- Last Split
- IPO Date
Brigit Biofarmaka Teknologi is a leading company in the healthcare sector, specializing in the development and commercialization of bio-pharmaceutical products. Its primary function is to research and produce cutting-edge therapies that address various medical conditions, enhancing patient outcomes and quality of life. The company operates at the intersection of biotechnology and pharmacology, focusing on leveraging natural compounds and innovative techniques to create effective and sustainable healthcare solutions. Brigit Biofarmaka Teknologi's impact spans multiple sectors, including traditional pharmaceuticals, alternative medicine, and nutraceuticals, positioning it as a key player in both preventive and therapeutic healthcare markets. As a forward-thinking entity, it holds a significant market role by advancing scientific research and supporting health initiatives that contribute to the global wellbeing. By fostering partnerships with research institutions and healthcare organizations, the company underscores its commitment to innovation and excellence in the bio-farmaka technology field.

Contact Information

Address: Rejosari RT.01 RW.07
Phone: 62 27 1599 2141